Terms: = Head and neck cancer AND AKAP9, AKAP350, 10142, ENSG00000127914, KIAA0803, Q99996, AKAP450, YOTIAO, PRKA9, HYPERION, MU-RMS-40_16A, CG-NAP AND Treatment
11 results:
1. TMEM16A as a potential treatment target for head and neck cancer.
Okuyama K; Yanamoto S
J Exp Clin Cancer Res; 2022 Jun; 41(1):196. PubMed ID: 35668455
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of Photon Isoeffective Dose Models Based on In Vitro and In Vivo Radiobiological Experiments for head and neck cancer Treated with BNCT.
Perotti Bernardini GF; Bortolussi S; Koivunoro H; Provenzano L; Ferrari C; Cansolino L; Postuma I; Carando DG; Kankaanranta L; Joensuu H; González SJ
Radiat Res; 2022 Aug; 198(2):134-144. PubMed ID: 35504003
[TBL] [Abstract] [Full Text] [Related]
3. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
[TBL] [Abstract] [Full Text] [Related]
4. hyperion Image Analysis Depicts a Preliminary Landscape of Tumor Immune Microenvironment in OSCC with Lymph Node Metastasis.
Xie S; Zhang XY; Shan XF; Yau V; Zhang JY; Wang W; Yan YP; Cai ZG
J Immunol Res; 2021; 2021():9975423. PubMed ID: 34239944
[TBL] [Abstract] [Full Text] [Related]
5. Molecular mechanism of action of new 1,4-naphthoquinones tethered to 1,2,3-1H-triazoles with cytotoxic and selective effect against oral squamous cell carcinoma.
Cavalcanti Chipoline I; Carolina Carvalho da Fonseca A; Ribeiro Machado da Costa G; Pereira de Souza M; Won-Held Rabelo V; de Queiroz LN; Luiz Ferraz de Souza T; Cardozo Paes de Almeida E; Alvarez Abreu P; Pontes B; Francisco Ferreira V; de Carvalho da Silva F; Robbs BK
Bioorg Chem; 2020 Aug; 101():103984. PubMed ID: 32554278
[TBL] [Abstract] [Full Text] [Related]
6. Automatic replanning of VMAT plans for different treatment machines: A template-based approach using constrained optimization.
Künzel LA; Dohm OS; Alber M; Zips D; Thorwarth D
Strahlenther Onkol; 2018 Oct; 194(10):921-928. PubMed ID: 29846751
[TBL] [Abstract] [Full Text] [Related]
7. Implementation of spot scanning dose optimization and dose calculation for helium ions in hyperion.
Fuchs H; Alber M; Schreiner T; Georg D
Med Phys; 2015 Sep; 42(9):5157-66. PubMed ID: 26328967
[TBL] [Abstract] [Full Text] [Related]
8. Impact of MLC properties and IMRT technique in meningioma and head-and-neck treatments.
Kantz S; Söhn M; Troeller A; Reiner M; Weingandt H; Alber M; Belka C; Ganswindt U
Radiat Oncol; 2015 Sep; 10():184. PubMed ID: 26328628
[TBL] [Abstract] [Full Text] [Related]
9. Is there a single spot size and grid for intensity modulated proton therapy? Simulation of head and neck, prostate and mesothelioma cases.
Widesott L; Lomax AJ; Schwarz M
Med Phys; 2012 Mar; 39(3):1298-308. PubMed ID: 22380362
[TBL] [Abstract] [Full Text] [Related]
10. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation.
Widesott L; Pierelli A; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Di Muzio N; Fazio F; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):589-96. PubMed ID: 18793962
[TBL] [Abstract] [Full Text] [Related]
11. [Fluence-modulated radiotherapy with an optimization-integrated sequencer].
Bär W; Alber M; Nüsslin F
Z Med Phys; 2003; 13(1):12-5. PubMed ID: 12723518
[TBL] [Abstract] [Full Text] [Related]
